Moreover, some LYC metabolites are bioactive, particularly apo-10′-lycopenoic acid (ALA), the major metabolite of LYC known to suppress hepatic steatosis and inflammation by stimulating sirtuin 1 (SIRT1). The gene discussed is SIRT1; the disease is fatty liver disease.